Yatin, S. ., Varadarajan, S. ., & Butterfield, D. . (2000). Vitamin E Prevents Alzheimer’s Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. Journal of Alzheimer’s Disease : JAD, 2(2), 123-131. https://doi.org/10.3233/jad-2000-2212

Yatin, S. ., Yatin, M. ., Varadarajan, S. ., Ain, K. ., & Butterfield, D. . (2001). Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity. Journal of Neuroscience Research, 63(5), 395-401. https://doi.org/10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q (Original work published 2001)

Butterfield, D. ., Yatin, S. ., & Link, C. . In vitro and in vivo protein oxidation induced by Alzheimer’s disease amyloid beta-peptide (1-42). Annals of the New York Academy of Sciences, 893, 265-8. https://doi.org/10.1111/j.1749-6632.1999.tb07833.x (Original work published 1999)

Yatin, S. ., Varadarajan, S. ., Link, C. ., & Butterfield, D. . (1969). In vitro and in vivo oxidative stress associated with Alzheimer’s amyloid beta-peptide (1-42). Neurobiology of Aging, 20(3), 325-30; discussion 339. https://doi.org/10.1016/s0197-4580(99)00056-1 (Original work published 1969)

Butterfield, D. ., Yatin, S. ., Varadarajan, S. ., & Koppal, T. . Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer’s disease. Methods in Enzymology, 309, 746-68. https://doi.org/10.1016/s0076-6879(99)09050-3 (Original work published 1999)

Yatin, S. ., Aksenova, M. ., Aksenov, M. ., Markesbery, W. ., Aulick, T. ., & Butterfield, D. . (1998). Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. Journal of Molecular Neuroscience : MN, 11(3), 183-97. https://doi.org/10.1385/JMN:11:3:183

Yatin, S. ., Yatin, M. ., Aulick, T. ., Ain, K. ., & Butterfield, D. . (1999). Alzheimer’s amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neuroscience Letters, 263(1), 17-20. https://doi.org/10.1016/s0304-3940(99)00101-9 (Original work published 1999)

Yatin, S. ., Aksenov, M. ., & Butterfield, D. . (1999). The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer’s disease. Neurochemical Research, 24(3), 427-35. https://doi.org/10.1023/a:1020997903147